The Precision Peptide Company Inc. PNGAF
OTC PK
| 07/31/2026 | 04/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 282.50% | -61.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 282.50% | -61.29% | |||
| Cost of Revenue | 64.75% | 125.93% | |||
| Gross Profit | 13,000.00% | -100.78% | |||
| SG&A Expenses | 246.04% | -66.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 232.58% | -66.11% | |||
| Operating Income | -230.74% | 66.24% | |||
| Income Before Tax | -238.89% | 62.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -238.89% | 62.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -238.89% | 62.64% | |||
| EBIT | -230.74% | 66.24% | |||
| EBITDA | -242.33% | 67.32% | |||
| EPS Basic | -198.88% | 64.40% | |||
| Normalized Basic EPS | -201.82% | 64.74% | |||
| EPS Diluted | -198.88% | 64.40% | |||
| Normalized Diluted EPS | -201.82% | 64.74% | |||
| Average Basic Shares Outstanding | 13.01% | 5.05% | |||
| Average Diluted Shares Outstanding | 13.01% | 5.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||